Brett Belongia
Corporate Officer/Principal bei ONCORUS, INC.
Aktive Positionen von Brett Belongia
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCORUS, INC. | Corporate Officer/Principal | - | - |
Karriereverlauf von Brett Belongia
Ehemalige bekannte Positionen von Brett Belongia
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Brett Belongia
| University of Arizona | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCORUS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Brett Belongia
- Erfahrung
